CONSMI: Contrastive Learning in the Simplified Molecular Input Line Entry System Helps Generate Better Molecules.

In recent years, the application of deep learning in molecular de novo design has gained significant attention. One successful approach involves using SMILES representations of molecules and treating the generation task as a text generation problem, yielding promising results. However, the generation of more effective and novel molecules remains a key research area. Due to the fact that a molecule can have multiple SMILES representations, it is not sufficient to consider only one of them for molecular generation. To make up for this deficiency, and also motivated by the advancements in contrastive learning in natural language processing, we propose a contrastive learning framework called CONSMI to learn more comprehensive SMILES representations. This framework leverages different SMILES representations of the same molecule as positive examples and other SMILES representations as negative examples for contrastive learning. The experimental results of generation tasks demonstrate that CONSMI significantly enhances the novelty of generated molecules while maintaining a high validity. Moreover, the generated molecules have similar chemical properties compared to the original dataset. Additionally, we find that CONSMI can achieve favorable results in classifier tasks, such as the compound-protein interaction task.

A controlled clinical study on efficacy and safety of periocular triamcinolone acetonide injection for treating ocular myasthenia gravis.

OBJECTIVE: To evaluate the efficacy and safety of peribulbar triamcinolone acetonide injection for treating ocular myasthenia gravis (OMG), with a comparison of traditional oral drug therapy. METHODS: A total of 22 patients with OMG who received periocular triamcinolone acetonide injection (initially 20 mg weekly, then once per month later if symptoms were improved) from July 2019 to July 2022 were evaluated by a comparison of symptom degree before and after treatment. Adverse reactions were also monitored during the period of treatment. The period of follow-up was more than 6 months. Additionally, a comparison of the treatment efficacy between this periocular injection and traditional oral administration was performed in OMG patients. RESULTS: After 4 weeks of treatment, the degree of ptosis in OMG patients decreased to -3.00 ± 0.69, compared to the value (-0.86 ± 1.32) before treatment. The degree of ophthalmoplegia also decreased from 3.12 ± 0.72 to 0.86 ± 0.88 (P < 0.001) after treatment. The achievement rates of minimal manifestations status (MMS)for ptosis and ophthalmoplegia after 4 week-treatment were 86.3% and 75%, respectively, while they were 50% and 30% in patients with traditional oral administration. There was statistically significant difference only in MMS (rather than symptom relief rate and generalization conversion rate) between two groups. No serious complications (except for intraorbital hematoma) were found in OMG patients during the treatment period. CONCLUSION: Repeated peribulbar injection of triamcinolone acetonide can effectively alleviate the initial symptoms of OMG patients. However, the evaluation of its long-term efficacy is still needed. CLINICAL TRIAL REGISTRY: This study has been clinically registered by Chinese Clinical Trial Registry (ChiCTR), first trial registration date:05/07/2019, registration number: ChiCTR1900024285.

Correlation of vitamin E level during pregnancy with maternal and neonatal health outcomes: a meta-analysis and systematic review.

OBJECTIVE: To investigate maternal vitamin E (tocopherol) levels during pregnancy and maternal and neonatal health (MNH) outcomes by using meta-analysis and systematic review of literature. METHODS: PubMed, Web of Science and Medline database were searched from database establishment to December 2022 to collect studies on the level of vitamin E (tocopherol) and pregnancy outcomes. Seven studies were finally included, after screening based on pre-specified eligibility and exclusion criteria. Included studies must have data on maternal vitamin E levels and maternal and infant pregnancy outcomes. Literature quality assessment was made using the Newcastle-Ottawa-Scale scoring standard, and meta-analysis was performed with the use of RevMan5.3. RESULTS: Seven studies (involving 6247 normal women and 658 adverse pregnancy outcomes women, 6905 total), all with a quality evaluation score ≥6 points, were included. The meta-analysis of the 7 studies revealed the presence of statistical heterogeneity in vitamin E data (P<0.1 and I2>50%), so a random-effects analysis was further carried out. Statistically lower serum vitamin E levels were determined in the adverse pregnancy outcome group compared with the normal group [SMD=4.44, 95% CI (2.44,6.43), P<0.001]. Descriptive analysis of the correlation of vitamin E levels with maternal and neonatal general information showed no statistical difference in vitamin E levels among mothers of different ages (<27 years, ≥27 years), P=0.214; however, women with BMI<18.5 kg/m2 showed a higher incidence of vitamin E deficiency than those with BMI ≥18.5 kg/m2 (χ2=15.173, P<0.05). Maternal vitamin E level with neonatal weight Z-Score >-2 was [1.793 (0.08, 4.514) mg/L], which was significantly lower than that of maternal vitamin E level with neonatal weight Z-Score ≤-2 [2.223 (0.899,6.958) mg/L], P=0.009. Maternal vitamin E levels with neonatal length Z-Score >-2 [1.746 (0.08, 4.514) mg/L] were significantly lower than those with neonatal length Z-Score ≤-2 [2.362 (1.380, 6.958) mg/L], P=0.006. CONCLUSION: Maternal vitamin E level is lower in those with adverse pregnancy outcomes than that in those with non-adverse pregnancy outcomes. Still, given the limited research on the correlation of vitamin E during pregnancy with maternal BMI and neonatal body length and weight, a large-scale and well-designed cohort study is needed for further analysis.

Clinicopathological features of corneal invasion by filtering bleb.

PURPOSE: To describe the clinicopathological characteristics and explore the possible etiology of cornea invasion by filtering bleb (CIFB) after filtering surgery. METHODS: We reviewed 22 patients treated for CIFB between March 2005 and March 2022. The patients were followed up for more than 1 year. Slit-lamp examination, optical coherence tomography (OCT), ultrasound biomicroscopy, and histopathological examination were performed to observe the morphology of the bleb and depth of corneal invasion. Depending on the severity of the lesion, treatments consisting of local massage, acupuncture separation, or surgical resection were administered. RESULTS: The mean age of the patients was 56.3 ± 8.8 years. All patients underwent filtering surgery in the moderate or advanced stage of glaucoma. The filtering bleb was closely connected with the cornea, and its posterior boundary was locally adhered. Forward displacement of the internal opening of the filtering bleb was found in 4 of 7 surgically treated patients. OCT and pathological examination showed that the filtering blebs invaded the corneal stroma. Removal of the adhesion of the posterior boundary of the filtering bleb by different treatment methods successfully improved the patients' conditions. CONCLUSION: Filtering blebs can invade the corneal stroma. Adhesion of the posterior boundary and forward displacement of the internal opening of the filtering bleb are the possible causes of CIFB. Removal of the adhesion of the posterior boundary of the filtering bleb can halt the progression of CIFB.

Study on the different responses of different winter wheat cultivars to dry hot wind.

Dry hot wind (DHW) is one of the main agro-meteorological disasters that occur during the grain filling stage of winter wheat in northern China. In this study, three major winter wheat cultivars planted at the Mazhuang experimental station, Xinji city, Hebei Province, including Henong 6119 (HN6119), Gaoyou 5218 (GY5218), and Jimai 325 (JM325), were analyzed. Through natural DHW and artificially simulated DHW experiments, we investigated how the physiological parameters of the three cultivars were affected on the day with DHW and the day before and after DHW occurred. Comparative analysis of the different responses among the physiological parameters of the three cultivars demonstrated that HN6119 experienced less leaf water loss by reducing its stomata conductance and transpiration rate under natural DHW conditions, while GY5218 and JM325 experienced more leaf water loss by increasing their stomata conductance and transpiration rates under natural DHW conditions. The net photosynthetic rate, transpiration rate, and stomata conductance of HN6119 recovered after the DHW conditions, while those of GY5218 and JM325 showed a continuously decreasing trend. The leaf photosynthetic water use efficiency decreased on DHW days because the net photosynthesis rate was reduced for HN6119, but the transpiration rate increased for GY5218 and JM325. HN6119 showed a significant positive correlation between physiological parameters, while GY5218 and JM325 showed a poor correlation after being affected by DHW conditions. The effect of artificial simulation under mild and severe DHW stress on the thousand kernel weight (TKW) of HN6119, GY5218 and JM325 was 0.01%, 3.51%, 3.57% and 0.36%, 8.12%, 8.84%, respectively. HN6119 showed better resistance to DHW, followed by GY5218, and JM325 showed the weakest resistance.

Epidemiological Analysis of Patients with Pre-Hospital First Aid in Keyouqian Banner, Hinggan League, Inner Mongolia.

Objective: To summarize the characteristics of patients calling the 120 emergency number for pre-hospital first aid in Keyouqian Banner, Hinggan League. Methods: The clinical data of adult patients with pre-hospital first aid from 2016 to 2018 were retrospectively analyzed. Results: There were 2711 cases with pre-hospital first aid. Males significantly outnumbered females. Young and middle-aged patients comprised 81.5%. Patients were mainly Han and Mongolians. Most injuries and illnesses occurred at home and on the road. The time to arrival of medical services was 30.34 ± 28.29 minutes. The proportion of pre-hospital first aid for trauma was the highest, followed by diseases concerning the cardiovascular and neurological systems. The proportion of patients with improved medical conditions after onsite first aid was 43.3%, the proportion with unchanged conditions was 51.7%, and the total mortality rate was 3.9%. Conclusion: The disease spectrum, ethnic distribution, age at onset, and pre-hospital first aid capabilities for outpatients were analyzed. These results may facilitate the establishment of a pre-hospital first aid system for the local prevention and control of acute and critical illnesses, increase the success rate of the region's pre-hospital first aid services, and improve the prognosis.

Treatment of acute acquired concomitant esotropia.

BACKGROUND: The treatment efficacy of botulinum toxin bilateral medial rectus injections for acute acquired concomitant esotropia (AACE) in adult is not clear. We characterize the effects of botulinum toxin injection in the treatment of AACE, especially in patients over 14 years old, and compared it with surgical treatment. METHODS: In this prospective, nonrandomized, controlled clinical study, patients with AACE in our hospital from March 2017 to March 2020 elected to receive bilateral medial rectus injections of botulinum toxin or to undergo extraocular muscle surgery. Ocular position and stereopsis were evaluated before and after treatment. RESULTS: A total of 60 patients were treated: 40 patients in the botulinum toxin group, and 20 patients in the surgery group. The botulinum toxin group included 31 cases ≥ 14 years of age and 9 cases < 14 years of age. After 1-3 botulinum injections, the cumulative initial success rate was 95% (38/40), and the recurrence rate was 22.5% (9/40). Nine children < 14 years of age were treated successfully, without recurrence. In the surgery group, the initial success rate after surgery was 75% (17/20), and the recurrence rate was 20% (4/20). There was no significant difference between groups in the rate of success rate or the rate of recurrence (P > 0.05). CONCLUSION: The injection of botulinum toxin has a good effect on AACE in adults and children. The outcomes achieved with injected botulinum toxin are similar to those achieved with surgery. TRIAL REGISTRATION: ChiCTR, ChiCTR2000032544 . Registered May 2, 2020, Retrospectively registered.

Quick and improved immune responses to inactivated H9N2 avian influenza vaccine by purified active fraction of Albizia julibrissin saponins.

BACKGROUND: H9N2 Low pathogenic avian influenza virus (LPAIV) raises public health concerns and its eradication in poultry becomes even more important in preventing influenza. AJSAF is a purified active saponin fraction from the stem bark of Albizzia julibrissin. In this study, AJSAF was evaluated for the adjuvant potentials on immune responses to inactivated H9N2 avian influenza virus vaccine (IH9V) in mice and chicken in comparison with commercially oil-adjuvant. RESULTS: AJSAF significantly induced faster and higher H9 subtype avian influenza virus antigen (H9-Ag)-specific IgG, IgG1, IgG2a and IgG2b antibody titers in mice and haemagglutination inhibition (HI) and IgY antibody levels in chicken immunized with IH9V. AJSAF also markedly promoted Con A-, LPS- and H9-Ag-stimulated splenocyte proliferation and natural killer cell activity. Furthermore, AJSAF significantly induced the production of both Th1 (IL-2 and IFN-γ) and Th2 (IL-10) cytokines, and up-regulated the mRNA expression levels of Th1 and Th2 cytokines and transcription factors in splenocytes from the IH9V-immunized mice. Although oil-formulated inactivated H9N2 avian influenza vaccine (CH9V) also elicited higher H9-Ag-specific IgG and IgG1 in mice and HI antibody titer in chicken, this robust humoral response was later produced. Moreover, serum IgG2a and IgG2b antibody titers in CH9V-immunized mice were significantly lower than those of IH9V alone group. CONCLUSIONS: AJSAF could improve antigen-specific humoral and cellular immune responses, and simultaneously trigger a Th1/Th2 response to IH9V. AJSAF might be a safe and efficacious adjuvant candidate for H9N2 avian influenza vaccine.

Local use of dexamethasone in the treatment of ocular myasthenia gravis.

BACKGROUND: At present, patients with ocular myasthenia gravis (OMG) are typically treated with systemic drugs. We investigated the use of dexamethasone injected in the peribulbar region or extraocular muscle to treat patients with OMG. METHODS: Patients with OMG were given dexamethasone via peribulbar injection or direct injection into the main paralyzed extraocular muscles, once a week, for 4-6 weeks. The severity of diplopia, blepharoptosis, eye position, and eye movement were evaluated before and after treatment. The duration of follow-up time was ≥6 months. RESULTS: Among the 14 patients with OMG who received this treatment, mean age was 38.7 ± 29.7 years. After treatment, symptoms were relieved in 12 patients (85.7%), 1 patient (7.1%) had partial response to treatment, and 1 patient (7.1%) had no response. Two patients (14.2%) experienced symptom recurrence during the follow-up period. CONCLUSIONS: Dexamethasone peribulbar or extraocular muscle injection is effective in the treatment of patients with OMG and may replace systemic drug therapy. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ChiCTR2000038863 , October 7, 2020.Retrospectively registered.

Evaluation and characteristics of immunological adjuvant activity of purified fraction of Albizia julibrissin saponins.

PURPOSE: The purified fraction of Albizia julibrissin saponins (AJSAF) was evaluated and characterized for the adjuvant activity on porcine reproductive and respiratory syndrome virus (PRRSV) vaccine. METHODS: The effects of AJSAF on serum PRRSV N protein-specific antibody titers, splenocyte proliferation, natural killer (NK) cell activity, mRNA expression of cytokines and transcription factors, secretion of cytokines, T cells response in splenocytes, as well as delayed type hypersensitivity (DTH) in the mice immunized PRRSV vaccine were determined by ELISA, MTT assay, flow cytometry and quantitative real-time PCR (qRT-PCR). RESULTS: AJSAF not only significantly enhanced the serum PRRSV N protein-specific IgG, IgG1, IgG2a and IgG2b antibody titers in the mice immunized with PRRSV CH-1R modified live vaccine (CH-1R MLV), inactivated vaccine (CH-1R IAV), and highly pathogenic JXA1-R modified live vaccine (JXA1-R MLV), but promoted the concanavalin A (Con A)-, lipopolysaccharide (LPS)- and PRRSV N protein-stimulated splenocyte proliferation, the activities of NK cells and delayed type hypersensitivity (DTH) in the mice immunized CH-1R MLV. AJSAF also remarkably induced the production of both Th1 (IFN-γ) and Th2 (IL-10) cytokines, and up-regulated the mRNA expression levels of Th1 cytokines (IFN-γ and IL-2) and transcription factors (T-bet and STAT4) as well as Th2 cytokines (IL-4 and IL-10) and transcription factors (GATA-3 and STAT6) in splenocytes from the CH-1R MLV-immunized mice. Furthermore, AJSAF markedly increased the frequencies of PRRSV N protein-specific Th1 (INF-γ+ and IL-2+) and Th2 (IL-4+ and IL-10+) CD4 T cells as well as Tc1 (INF-γ+ and IL-2+) and Tc2 (IL-4+ and IL-10+) CD8 T cells in splenocytes from the CH-1R MLV-immunized mice. CONCLUSIONS: Our results demonstrated that AJSAF had a potential to enhance and improve immune responses and elicit both Th1/Th2 and Tc1/Tc2 response to PRRSV vaccine, and that AJSAF would be a promising adjuvant candidate for PRRSV vaccine.

Treatment of adults with accommodative esotropia using implantable collamer lenses.

PURPOSE: To evaluate the efficacy and safety of the implantation of an implantable collamer lens (ICL) for accommodative esotropia in adults. METHODS: From May 2011 to May 2012, 3 adults with complete accommodative esotropia underwent ICL implantation with 12 months of follow-up. Inclusion criteria included having an appropriate anterior chamber depth and endothelial cell count, and hyperopia that was not typically responding well to corneal refractive surgery. Preoperative and postoperative visual acuity, refraction, eye position, corneal endothelial cell count, intraocular pressure, anterior chamber depth, and complications (intraoperative and postoperative) were observed. RESULTS: Cycloplegic refraction changed from 6.04 ± 0.53 preoperatively to 0.41 ± 0.21 postoperatively (t = 38.9, P < .001). Before surgery, the average esotropia at near (without glasses) was 25 prism diopters (range: 20 to 30 prism diopters). After surgery, all patients achieved orthophoria or microesophoria. Postoperative uncorrected visual acuity at distance and near significantly increased (P < .05), best-corrected visual acuity at near did not change significantly (P = .36), and best-corrected visual acuity at distance improved significantly (P = .03). The average decline in corneal endothelium cell density was 10.3% and remained stable during the follow-up period. One patient complained of glare when driving at night after surgery and this phenomenon gradually disappeared after 3 months. No other intraoperative and postoperative complications, such as ICL-related iris depigmentation, atrophy, glaucoma, or cataracts (partial or complete), were observed. CONCLUSIONS: The preliminary results of this small case study demonstrated that the use of ICL implantation to treat accommodative esotropia in adults was effective and safe; however, a larger scale study is necessary.

Hyperopic corneal refractive surgery in patients with accommodative esotropia and amblyopia.

PURPOSE: To explore whether hyperopic excimer corneal refractive surgery can affect ocular alignment and stereopsis in patients with both accommodative esotropia and amblyopia. METHODS: In this prospective study, 26 eyes of 13 patients with accommodative esotropia and amblyopia underwent bilateral hyperopic corneal refractive surgery: 9 patients underwent laser in situ keratomileusis (LASIK); 4, laser epithelial keratomileusis (LASEK). The main ocular examinations included pre- and postoperative best-corrected and uncorrected visual acuity, refractive error, ocular alignment, and stereopsis. RESULTS: Preoperative cycloplegic refraction in the right eyes was +5.64 ± 2.09 D; in the left eyes, +5.91 ± 1.97 D. After surgery, refraction in the right eyes was +1.13 ± 1.21 D; in the left eyes, +1.44 ±1.53 D. The mean logMAR uncorrected visual acuity was 0.46 ± 0.30 before surgery and 0.32 ± 0.25 after surgery (t = 5.72, P = 0.001). The mean pre- and postoperative best-corrected visual acuity were 0.31 ± 0.28 and 0.29 ± 0.25, respectively; there was no significant difference between the two groups (t = 1.23, P = 0.22). The average uncorrected esotropia was 37.92(Δ) ± 9.12(Δ) before surgery and 2.76(Δ) ± 2.80(Δ) after (P < 0.001). Using a synoptophore, 2 patients (15.3%) had preoperative stereopsis and 11 patients (84.6%) had postoperative stereopsis. No patients experienced lower stereopsis postoperatively. CONCLUSIONS: In this cohort, hyperopic corneal refractive surgery can improve the alignment, uncorrected visual acuity, and stereopsis in patients with accommodative esotropia and amblyopia.

Adjuvant-active fraction from Albizia julibrissin saponins improves immune responses by inducing cytokine and chemokine at the site of injection.

The total saponin from the stem bark of Albizia julibrissin (AJSt) has previously showed the adjuvant potentials in mice. In this study, AJSt was subjected to resin column chromatography to afford four fractions (AJS30, AJS50, AJS75 and AJS95), and these fractions were further compared for the hemolytic activities and adjuvant potentials on the immune response to ovalbumin (OVA) and recombinant fowl pox virus vector-based avian influenza vaccine (rFPV). AJSt, AJS50, AJS75 and AJS95 showed a slight hemolytic effect. AJSt, AJS50 and AJS75 significantly enhanced not only the concanavalin A (Con A)-, lipopolysaccharide (LPS)- and antigen-stimulated splenocyte proliferation, but also serum antigen-specific IgG, IgG1, IgG2a and IgG2b antibody titers in the mice immunized with OVA and rFPV. AJSt, AJS50 and AJS75 also significantly promoted the NK cell activity and delayed-type hypersensitivity (DTH) in the OVA-immunized mice. Furthermore, the mechanisms of adjuvant action were explored by determining the effects of AJS75 on cytokines and chemokines at the site of injection using antibody array. AJS75 induced or up-regulated the protein expression of 12 cytokines (IL-12p40, IL-12p40/p70, IFN-γ, IL-13, IL-1ß, IL-6, IL-10, TNF-α, sTNFR I, sTNFR III, IL-3 and IL-9) and 10 chemokines (Eotaxin, I-TAC, MIG, MIP-1α, RANTES, TECK, Fracatlkine, FasL, M-CSF and GM-CSF) in the injected muscles. The results suggested that AJS75, the most adjuvant-active fraction of AJSt, could improve antigen-specific both cellular and humoral immune responses and simultaneously elicit a Th1/Th2 response by inducing cytokine and chemokine at the site of injection.

Screening and appraisal for immunological adjuvant-active fractions from Platycodon grandiflorum total saponins.

In this study, the total saponins from the root of Platycodon grandiflorum (PGS(t)) was subjected to D101 macroreticular resin column chromatography to afford four fractions (PGS30, PGS50, PGS75 and PGS95). PGS(t) and its four fractions were evaluated and compared for the haemolytic activities and adjuvant potentials on the specific cellular and humoral immune responses of ICR mice against recombinant hepatitis B surface antigen (HBsAg). PGS(t), PGS30, PGS50, PGS75, and PGS75 showed a slight haemolytic effect, with their concentration inducing 50% of the maximum haemolysis (HD50) being 16.13 ± 0.81, >200, 17.53 ± 0.24, 20.16 ± 0.76, 76.31 ± 2.20 µg/mL against 0.5% rabbit red blood cell, respectively. PGS(t), PGS50, and PGS75 significantly not only enhanced the Con A-, lipopolysaccharide-, and HBsAg-induced splenocyte proliferation, but promoted the killing activities of natural killer (NK) cells from splenocytes in HBsAg-immunized mice (P < 0.01 or P < 0.001). HBsAg-specific IgG, IgG1, IgG2a, and IgG2b antibody levels in serum were also significantly enhanced by PGS(t), PGS50, and PGS75 compared with HBsAg control group (P < 0.05, P < 0.01, or P < 0.001). Moreover, the adjuvant effects of PGS50 and PGS75 on the cellular immune responses and HBsAg-specific IgG2a and IgG2b antibody responses were more significant than those of Alum, PGS30, and PGS95. The results indicated that PGS50 and PGS75 could improve both cellular and humoral immune responses, and elicit a balanced Th1/Th2 response to HBsAg in mice, and that PGS75 may be developed as an ideal candidate adjuvant for hepatitis B vaccine.

[Clinical study of phacoemulsification with NeoSoniX handpiece].

OBJECTIVE: To evaluate the outcomes of phacoemulsification with NeoSoniX handpiece. METHODS: It was a prospective random controlled clinical trial. Six hundred and fifty-nine cases (659 eyes) having phacoemulsification were prospectively comprised in this study. All cases were divided into two groups randomly. Group 1(NeoSoniX handpiece) include 317 cases. Group 2 (standard handpiece) include 342 cases. Preoperative measurements included best correct visual acuity (BCVA) and cataract grade according to the Emery classification. Intraoperative measurements included active power (AP) and effective phaco time (EPT). Postoperative measurements included BCVA and corneal edema. RESULTS: Grade I to III nuclear sclerosis, the AP was 3.53% +/- 1.76% with NeoSoniX and 3.84% +/- 1.93 % with standard handpiece, the EPT was (0.23 +/- 0.15) minutes and (0.25 +/- 0.19) minutes, respectively. There was no significant difference in the postoperative BCVA and cornea edema between the two groups. Grade IV or V nuclear sclerosis, the AP was 6.31% +/- 2.78 % with NeoSoniX and 9.45% +/- 4.17 % with standard handpiece, the EPT was (0.55 +/- 0.28) minutes and (0.83 +/- 0.44) minutes, respectively. There was significant difference in the postoperative 1 day BCVA and cornea edema between the two groups. There was significant difference in the postoperative 7 days BCVA and cornea edema between the two groups. CONCLUSIONS: Ultrasound energy consumption with NeoSoniX was significantly less than with US alone in emulsifying cataracts of optimum density and dense hard cataracts.

[Comparative study of gentamycin and povidone-iodine on eliminating the conjunctival bacteria].

OBJECTIVE: To study the efficacy of gentamycin, 0.5% povidone-iodine and 5.0% povidone-iodine in eliminating rate of positive conjunctival bacteria cultures and aqueous humor contamination, and to observe their adverse effects. METHODS: It was a comparative study. Three hundred patients (300 eyes) were randomized to three groups: gentamycin group, 0.5% povidone-iodine group and 5.0% povidone-iodine group. All patients received 1-day (6 times) topical application of 0.3% ofloxacin before surgery. Approximately 5 minutes before surgery, the conjunctival sac was irrigated with 5 - 8 ml gentamycin, 0.5% povidone-iodine or 5.0% povidone-iodine, correspondingly. Conjunctival cultures were obtained at the following time points: before receiving any topical medications; after application of 1-day topical 0.3% ofloxacin, before irrigating the conjunctival sac; immediately before surgery approximately 5 minutes after conjunctival sac irrigation and at the end of the surgery. Anterior chamber aspirates were obtained at the beginning of the surgery. Bacteria isolated were identified and antibiotic susceptibility was determined. The rate of positive conjunctival cultures among each group was compared and significance of the difference was tested with the Pearson chi-square test. RESULTS: Rate of positive conjunctival cultures before the conjunctival irrigation was 79.7%, 76.6% and 77.8% in the gentamycin group, 0.5% povidone-iodine group and 5.0% povidone-iodine group, respectively. The difference between these three groups was not statistically significant (chi2 = 0.28, P = 0.86). At the end of surgery, the rate of positive conjunctival cultures in these three groups was 11.7%, 8.3% and 6.3%, respectively. The difference between these three groups was also not statistically significant (chi2 = 1.74, P = 0.41). The average rate of anterior aqueous contamination was 4.9% and there was no significant difference among these three groups (P > 0.05). CONCLUSIONS: Both 0.5% povidone-iodine and 5.0% povidone-iodine using for irrigating conjunctival sac are safe. Gentamycin, 0.5% povidone-iodine and 5.0% povidone-iodine have similar effects on the reduction of the bacteria in conjunctival sac.

The immune response and protective efficacy of vaccination with oral microparticle Aeromonas sobria vaccine in mice.

The effect of an oral alginate microparticle Aeromonas sobria vaccine on immune response and protection of mice was investigated. The formalin-killed cultures (FKC) of A. sobria strain Z-1 treated with three methods were incorporated into alginate microparticles, and the encapsulated vaccines were orally used for immunizing mice. Four weeks after immunization, the serum agglutinating antibody titers, bactericidal activity of leucocytes and relative percent survival (RPS) of mice immunized orally with three microparticle vaccines were significantly higher than those of control mice. Among the immune efficacy of 3 microparticle vaccines, vaccine prepared directly from FKC (MVC) was the most, vaccine from FKC treated with freeze-melt method (MVCF) secondly, and vaccine from FKC treated with ultrasonic wave (MVCU) the worst. The serum agglutinating antibody titers and phagocytic activity of the blood monocytes in mice immunized orally with MVC reached a level equivalent to those of injection with FKC, and were significantly higher than those of control group. Moreover, from the 7th to 12th weeks, the serum agglutinating antibody titers in the MVC-immunized mice was significantly higher than those of injection with FKC. The RPS of mice immunized orally with MVC was 87.5%, while 100% of mice immunized orally with FKC and also the control mice died. These results demonstrated that oral alginate microparticle of A. sobria strain Z-1 was immunogenic and conferred protective immunity in mice, and could be used as a candidate vector system of oral vaccine of Aeromonas.